Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Synapses MARKed for Failure After PSD-95 Phosphorylation
21 January 2007. In flies, the microtubule/MAP-affinity regulating kinase (MARK) promotes neurodegeneration by kicking off a cascade of tau phosphorylation that renders tau toxic and leads to neurofibrillary tangles. But that is far from the whole story with MARK, as a paper in this week’s Neuron suggests. Bingwei Lu and colleagues at Stanford University in Palo Alto, California, show that the Drosophila MARK homolog also directly affects synapse structure and function. Looking at peripheral synapses, the scientists find that Dlg, the fly homolog of the postsynaptic protein PSD-95, is a major substrate for MARK. Moreover, they establish that MARK phosphorylation regulates the assembly of PSD-95/Dlg at the synapse. This finding positions the kinase as a critical regulator of synapse formation.

These effects of MARK may help shape the synapse as a whole. A second paper, briefly mentioned below, shows that PSD-95 can reach across the synapse to regulate presynaptic function, as well. That work, from Yasunori Hayashi and colleagues at MIT in Cambridge, Massachusetts, appears today in an early online release in Nature Neuroscience.

It has been MARK’s effects on tau that have most interested AD researchers (see review by Drewes, 2004). When MARK phosphorylates tau, tau comes off of microtubules, leaving them destabilized. At the same time, phosphorylation by MARK primes tau for hyperphosphorylation by additional kinases including GSK3 and Cdk5, and this in turn promotes aggregation of tau into neurofibrillary tangles. Early on, MARK showed up localized with neurofibrillary tangles in AD brain tissue (Chin et al., 2000), and in current work published this past Wednesday, Lu’s lab begins to lay out how PAR-1 itself is regulated (Wang et al., 2007).

Previous work from Lu’s lab showed that overexpression of the Drosophila MARK homolog PAR-1 leads to tau-dependent neurodegeneration in flies (see ARF related news story). This led to the speculation that increases in MARK activity could promote the formation of toxic tau species in Alzheimer disease. But PAR-1 overexpression caused a stronger neurodegeneration phenotype than tau itself, suggesting to the researchers that PAR-1 might have additional substrates. When they went looking for those, first author Yali Zhang found PAR-1 was enriched at the postsynaptic region of the neuromuscular junction synapses in Drosophila larvae. Either knockout or overexpression of PAR-1 caused defects in synapse formation—PAR-1 mutants had more synapses on smaller boutons, while PAR-1 overexpressers had fewer boutons and an immature synapse structure.

In PAR-1 overexpressing flies, Dlg/PSD-95 was no longer targeted to postsynaptic structures, but instead was dispersed throughout the muscle cells. Both in-vitro and in-vivo experiments showed that PAR-1 phosphorylated Dlg at a serine residue in a region known to be involved in synaptic targeting. By expressing either a nonphosphorylatable or a phosphomimetic mutant, the investigators demonstrated that the phosphorylation prevented the recruitment of Dlg to synapses in vivo.

Additional experiments supported the idea that Dlg is the main target by which PAR-1 overexpression disrupts synapse development. But loss of PAR-1 also caused synaptic troubles. Ultrastructural analysis revealed exaggerated growth of postsynaptic reticular structures. Consistent with these changes, either overexpression or underexpression of PAR-1 affected synaptic transmission, with PAR-1 excess (or Dlg knockout) reducing transmission and PAR-1 overactivity increasing it.

The results show a previously unrecognized role for MARK in the physiology of a neuron. Not only does the kinase regulate microtubule dynamics via tau phosphorylation, but it also influences the formation of synapses via PSD-95. This work was done in larval neuromuscular junctions, and it will be important to see if the same holds true in central synapses, and how MARK might affect mature synapses in higher organisms. An open question for researchers to tackle is whether the activation of MARK and phosphorylation of PSD-95 contribute to the early synapse loss observed in AD. Certainly, PSD-95 is showing up in AD-related research with increasing frequency. For one, PSD-95 is known to be important for anchoring AMPA receptors in the postsynaptic membrane, a process thought to be affected by the amyloid-β protein.

There are two sides to every synapse, and PAR-1/MARK overexpression affects presynaptic function in flies, too. This should not be too surprising, given that the structure and function of pre- and postsynaptic regions are tightly linked. That’s where Hayashi’s paper ties in. It shows that PSD-95 itself takes part in that coordination. In today’s online issue of Nature Neuroscience, first author Kensuke Futai and colleagues show that postsynaptic PSD-95 links up with the transmembrane protein neuroligin to reach across the synapse and modulate presynaptic neurotransmitter release. The activity of PSD-95 can thus alter presynaptic short-term plasticity, observed here in hippocampal neurons in slice cultures. This effect provides a mechanism for dynamic retrograde signaling across the synapse, a process that helps coordinate both the structure and function of the two-sided communication unit.

Both papers bring home the point that even modest changes in PSD-95 function, for example, under the influence of deregulated MARK, could spell big trouble for synapses.—Pat McCaffrey.

References:
Zhang Y, Guo H, Kwan H, Wang J, Kosek J, Bingwei L. PAR-1 kinase phosphorylates Dlg and regulates its postsynaptic targeting at the Drosophila neuromuscular junction. Neuron. 2007 Jan 18; 53:201-215. Abstract

Futai K, Kim MJ, Hashikawa T, Scheiffele P, Sheng M, Hayashi Y. Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nature Neuroscience. 2007 Jan 21; Advanced online publication. Abstract

 
Comments on News and Primary Papers
  Primary Papers: PAR-1 kinase phosphorylates Dlg and regulates its postsynaptic targeting at the Drosophila neuromuscular junction.

Comment by:  Jane Sullivan
Submitted 23 January 2007  |  Permalink Posted 23 January 2007

This study convincingly demonstrates that PAR-1 phosphorylation of Dlg reduces the amount of Dlg localized to postsynaptic sites, and consequently decreases excitatory transmission. PAR-1 and Dlg are the fly homologs of mammalian proteins MARK and PSD-95, respectively. In mice, knocking out PSD-95 decreases excitatory transmission through the selective removal of AMPA-type glutamate receptors at synapses (Beique et al., 2006). Curiously, elevated levels of amyloid-β have been linked to reductions in levels of synaptic PSD-95 (Gylys et al., 2004; Almeida et al., 2005; Roselli et al., 2005) and surface AMPA receptors (Almeida et al., 2005; Roselli et al., 2005; Hsieh et al., 2006), and also to depression of AMPA receptor-mediated synaptic transmission (Kamenetz et al., 2003; Hsieh et al., 2006; Ting et al., 2006). Together these findings raise the possibility that elevated levels of amyloid-β could be decreasing excitatory transmission in AD by activating MARK, leading to phosphorylation of PSD-95 and subsequent removal of synaptic AMPA receptors.

Although PAR-1/MARK have...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad